会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • INHIBITION OF DNA POLYMERASES TO AUGMENT CHEMOTHERAPEUTIC AND ANTIMICROBIAL AGENTS
    • DNA聚合酶对全球化疗与抗菌药物的抑制作用
    • US20110236507A1
    • 2011-09-29
    • US13131936
    • 2009-04-22
    • R. Stephen LloydIrina G. MinkoAmanda K. McCullough
    • R. Stephen LloydIrina G. MinkoAmanda K. McCullough
    • A61K33/24A61K31/198A61K31/675A61K31/255A61K31/407C12Q1/48C12Q1/68A61P35/00A61P31/00
    • A61K45/06A61K31/195A61K31/56A61K31/70A61K33/24G01N2333/9126G01N2500/02A61K2300/00
    • Disclosed herein is the identification of human DNA polymerase κ (pol κ) as the polymerase that mediates repair of DNA containing interstrand cros slinks (ICLs). The mechanism of action of a number of chemotherapeutic and antimicrobial agents is the induction of ICLs. Thus, provided herein is a method of enhancing the efficacy of a chemotherapeutic or antimicrobial agent in a subject, including selecting a subject in need of treatment with an ICL-inducing agent and administering to the subject an ICL-inducing agent and a therapeutically effective amount of an inhibitor of pol κ. Subjects in need of treatment with an ICL-inducing agent, include, for example, subjects diagnosed with a hyperproliferative disease, an autoimmune disease or an infectious disease. Also provided is a composition for treating a hyperproliferative disease, an autoimmune disease or an infectious disease, comprising an ICL-inducing agent and an amount of an inhibitor of pol κ sufficient to enhance the efficacy of the ICL-inducing agent. Further provided is a method of identifying a DNA polymerase inhibitor.
    • 本文公开了人DNA聚合酶的鉴定; (pol&kgr))作为介导修复含有串联链的DNA(ICL)的聚合酶。 许多化学治疗和抗微生物剂的作用机制是ICL的诱导。 因此,本文提供的是提高受试者中化学治疗剂或抗微生物剂的功效的方法,包括选择需要用ICL诱导剂治疗的受试者,并向受试者施用ICL诱导剂和治疗有效量 的抑制剂。 需要用ICL诱导剂治疗的受试者包括例如被诊断患有过度增殖性疾病,自身免疫性疾病或感染性疾病的受试者。 还提供了用于治疗过度增殖性疾病,自身免疫性疾病或感染性疾病的组合物,其包含ICL诱导剂和一定量的抑制剂, 足以增强ICL诱导剂的功效。 进一步提供鉴定DNA聚合酶抑制剂的方法。